Delaware
|
000-50644
|
77-0492262
|
(State or other jurisdiction of incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification Number)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02. | Results of Operations and Financial Condition. |
Item 9.01.
|
Financial Statements and Exhibits.
|
(d)
|
Exhibits.
|
Exhibit No.
|
Description
|
Press Release of Cutera, Inc. dated as of November 5, 2012.
|
CUTERA, INC.
|
|||
Date: November 5, 2012
|
/s/ KEVIN P. CONNORS
|
||
Kevin P. Connors
|
|||
President and Chief Executive Officer
|
|
·
|
Revenue grew 28%, to $19.4 million.
|
|
·
|
Net loss was $892,000, or $0.06 per diluted share, which included $1.2 million of non-cash stock-based compensation, amortization of intangibles, and depreciation.
|
|
·
|
truSculpt product commenced shipments mid-quarter and contributed to revenue growth
|
|
·
|
Board of Directors approved a stock repurchase program for up to $10 million pursuant to a 10b5-1 plan.
|
September 30,
|
June 30,
|
September 30,
|
||||||||||
2012
|
2012
|
2011
|
||||||||||
Assets
|
||||||||||||
Current assets:
|
||||||||||||
Cash and cash equivalents
|
$ | 24,334 | $ | 17,788 | $ | 13,874 | ||||||
Marketable investments
|
55,795 | 62,794 | 74,502 | |||||||||
Accounts receivable, net
|
7,845 | 6,203 | 4,085 | |||||||||
Inventories
|
12,477 | 12,722 | 9,659 | |||||||||
Deferred tax asset
|
49 | 52 | 17 | |||||||||
Other current assets and prepaid expenses
|
1,443 | 1,443 | 1,841 | |||||||||
Total current assets
|
101,943 | 101,002 | 103,978 | |||||||||
Property and equipment, net
|
885 | 946 | 643 | |||||||||
Long-term investments
|
1,050 | 840 | 3,014 | |||||||||
Deferred tax asset, net of current portion
|
470 | 463 | 345 | |||||||||
Intangibles, net
|
2,876 | 3,186 | 493 | |||||||||
Goodwill
|
1,339 | 1,339 | - | |||||||||
Other long-term assets
|
517 | 539 | 493 | |||||||||
Total assets
|
$ | 109,080 | $ | 108,315 | $ | 108,966 | ||||||
Liabilities and Stockholders' Equity
|
||||||||||||
Current liabilities:
|
||||||||||||
Accounts payable
|
$ | 2,297 | $ | 2,199 | $ | 2,151 | ||||||
Accrued liabilities
|
9,486 | 9,382 | 7,339 | |||||||||
Deferred revenue
|
6,299 | 6,285 | 5,447 | |||||||||
Total current liabilities
|
18,082 | 17,866 | 14,937 | |||||||||
Deferred rent
|
1,347 | 1,400 | 1,432 | |||||||||
Deferred revenue, net of current portion
|
1,411 | 905 | 775 | |||||||||
Income tax liability
|
471 | 469 | 489 | |||||||||
Total liabilities
|
21,311 | 20,640 | 17,633 | |||||||||
Stockholders’ equity:
|
||||||||||||
Common stock
|
14 | 14 | 14 | |||||||||
Additional paid-in capital
|
98,865 | 98,044 | 94,594 | |||||||||
Retained earnings (Accumulated deficit)
|
(10,950 | ) | (10,058 | ) | (2,438 | ) | ||||||
Accumulated other comprehensive loss
|
(160 | ) | (325 | ) | (837 | ) | ||||||
Total stockholders' equity
|
87,769 | 87,675 | 91,333 | |||||||||
Total liabilities and stockholders' equity
|
$ | 109,080 | $ | 108,315 | $ | 108,966 |
Three Months Ended
|
||||||||||||
September 30,
|
June 30,
|
September 30,
|
||||||||||
2012
|
2012
|
2011
|
||||||||||
Net revenue
|
$ | 19,426 | $ | 19,591 | $ | 15,232 | ||||||
Cost of revenue
|
8,828 | 9,274 | 6,772 | |||||||||
Gross profit
|
10,598 | 10,317 | 8,460 | |||||||||
Operating expenses:
|
||||||||||||
Sales and marketing
|
7,014 | 7,112 | 6,426 | |||||||||
Research and development
|
2,217 | 1,872 | 2,352 | |||||||||
General and administrative
|
2,475 | 2,854 | 2,310 | |||||||||
Total operating expenses
|
11,706 | 11,838 | 11,088 | |||||||||
Loss from operations
|
(1,108 | ) | (1,521 | ) | (2,628 | ) | ||||||
Interest and other income, net
|
152 | 144 | 91 | |||||||||
Loss before income taxes
|
(956 | ) | (1,377 | ) | (2,537 | ) | ||||||
Provision (benefit) for income taxes
|
(64 | ) | 89 | 326 | ||||||||
Net loss
|
$ | (892 | ) | $ | (1,466 | ) | $ | (2,863 | ) | |||
Net loss per share:
|
||||||||||||
Basic and Diluted
|
$ | (0.06 | ) | $ | (0.10 | ) | $ | (0.21 | ) | |||
Weighted-average number of shares used in per share calculations:
|
||||||||||||
Basic and Diluted
|
14,127 | 14,095 | 13,862 |
Three Months Ended
|
||||||||||||
September 30,
|
June 30,
|
September 30,
|
||||||||||
2012
|
2012
|
2011
|
||||||||||
Cash flows from operating activities:
|
||||||||||||
Net loss
|
$ | (892 | ) | $ | (1,466 | ) | $ | (2,863 | ) | |||
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||||||
Stock-based compensation
|
809 | 787 | 894 | |||||||||
Tax benefit from stock-based compensation
|
- | - | 5 | |||||||||
Excess tax benefit related to stock-based compensation
|
- | - | (5 | ) | ||||||||
Depreciation and amortization
|
418 | 425 | 164 | |||||||||
Other
|
(113 | ) | (14 | ) | 270 | |||||||
Changes in assets and liabilities:
|
||||||||||||
Accounts receivable
|
(1,641 | ) | (1,697 | ) | (830 | ) | ||||||
Inventories
|
245 | 712 | (1,358 | ) | ||||||||
Other current assets and prepaid expenses
|
214 | 59 | 512 | |||||||||
Other long-term assets
|
22 | (81 | ) | (493 | ) | |||||||
Accounts payable
|
98 | (475 | ) | (29 | ) | |||||||
Accrued liabilities
|
78 | 420 | 411 | |||||||||
Deferred rent
|
(27 | ) | (24 | ) | (4 | ) | ||||||
Deferred revenue
|
520 | 503 | (150 | ) | ||||||||
Income tax liability
|
2 | - | (5 | ) | ||||||||
Net cash used in operating activities
|
(267 | ) | (851 | ) | (3,481 | ) | ||||||
Cash flows from investing activities:
|
||||||||||||
Acquisition of property and equipment
|
(47 | ) | (34 | ) | (24 | ) | ||||||
Disposal of property and equipment
|
- | - | 36 | |||||||||
Proceeds from sales of marketable and long-term investments
|
8,566 | 7,066 | 7,156 | |||||||||
Proceeds from maturities of marketable investments
|
14,610 | 8,700 | 6,649 | |||||||||
Purchase of marketable investments
|
(16,328 | ) | (10,094 | ) | (14,130 | ) | ||||||
Net cash provided by (used in) investing activities
|
6,801 | 5,638 | (313 | ) | ||||||||
Cash flows from financing activities:
|
||||||||||||
Proceeds from exercise of stock options and employee stock purchase plan
|
12 | 214 | 180 | |||||||||
Excess tax benefit related to stock-based compensation
|
- | - | 5 | |||||||||
Net cash provided by financing activities
|
12 | 214 | 185 | |||||||||
Net increase (decrease) in cash and cash equivalents
|
6,546 | 5,001 | (3,609 | ) | ||||||||
Cash and cash equivalents at beginning of period
|
17,788 | 12,787 | 17,483 | |||||||||
Cash and cash equivalents at end of period
|
$ | 24,334 | $ | 17,788 | $ | 13,874 |
Three Months Ended
|
|||||||||||||||
September 30,
|
% of
|
June 30,
|
% of
|
September 30,
|
% of
|
||||||||||
2012
|
Revenue
|
2012
|
Revenue
|
2011
|
Revenue
|
||||||||||
Revenue By Geography:
|
|||||||||||||||
United States
|
$
|
7,796
|
40%
|
$
|
7,834
|
40%
|
$
|
6,037
|
40%
|
||||||
International
|
11,630
|
60%
|
11,757
|
60%
|
9,195
|
60%
|
|||||||||
$
|
19,426
|
$
|
19,591
|
$
|
15,232
|
||||||||||
Revenue By Product Category:
|
|||||||||||||||
Products
|
$
|
12,047
|
62%
|
$
|
11,690
|
60%
|
$
|
8,975
|
59%
|
||||||
Upgrades
|
487
|
3%
|
797
|
4%
|
687
|
4%
|
|||||||||
Service
|
4,298
|
22%
|
4,435
|
23%
|
3,227
|
21%
|
|||||||||
Titan hand piece refills
|
1,226
|
6%
|
1,216
|
6%
|
1,031
|
7%
|
|||||||||
Dermal fillers and cosmeceuticals
|
1,368
|
7%
|
1,453
|
7%
|
1,312
|
9%
|
|||||||||
$
|
19,426
|
$
|
19,591
|
$
|
15,232
|
Three Months Ended
|
||||||||||||
September 30,
|
June 30,
|
September 30,
|
||||||||||
2012
|
2012
|
2011
|
||||||||||
Pre-tax Stock-Based Compensation Expense:
|
||||||||||||
Cost of revenue
|
$
|
169
|
$
|
168
|
$
|
179
|
||||||
Sales and marketing
|
177
|
159
|
210
|
|||||||||
Research and development
|
126
|
147
|
184
|
|||||||||
General and administrative
|
337
|
313
|
321
|
|||||||||
$
|
809
|
$
|
787
|
$
|
894
|